University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
Department of Molecular Biology and Biophysics, UConn Health Center, Farmington, CT, USA.
EMBO Rep. 2021 Apr 7;22(4):e50835. doi: 10.15252/embr.202050835. Epub 2021 Feb 15.
Regulation of mRNA stability and translation plays a critical role in determining protein abundance within cells. Processing bodies (P-bodies) are critical regulators of these processes. Here, we report that the Pim1 and 3 protein kinases bind to the P-body protein enhancer of mRNA decapping 3 (EDC3) and phosphorylate EDC3 on serine (S)161, thereby modifying P-body assembly. EDC3 phosphorylation is highly elevated in many tumor types, is reduced upon treatment of cells with kinase inhibitors, and blocks the localization of EDC3 to P-bodies. Prostate cancer cells harboring an EDC3 S161A mutation show markedly decreased growth, migration, and invasion in tissue culture and in xenograft models. Consistent with these phenotypic changes, the expression of integrin β1 and α6 mRNA and protein is reduced in these mutated cells. These results demonstrate that EDC3 phosphorylation regulates multiple cancer-relevant functions and suggest that modulation of P-body activity may represent a new paradigm for cancer treatment.
mRNA 稳定性和翻译的调节在决定细胞内蛋白质丰度方面起着关键作用。处理体(P 体)是这些过程的关键调节剂。在这里,我们报告说 Pim1 和 3 蛋白激酶与 P 体蛋白 mRNA 去帽增强因子 3(EDC3)结合,并在丝氨酸(S)161 上磷酸化 EDC3,从而修饰 P 体组装。EDC3 磷酸化在许多肿瘤类型中高度升高,在用激酶抑制剂处理细胞后降低,并阻止 EDC3 定位于 P 体。携带 EDC3 S161A 突变的前列腺癌细胞在组织培养和异种移植模型中显示出明显的生长、迁移和侵袭减少。与这些表型变化一致,这些突变细胞中整合素 β1 和 α6 mRNA 和蛋白的表达减少。这些结果表明 EDC3 磷酸化调节多种与癌症相关的功能,并表明 P 体活性的调节可能代表癌症治疗的新范例。